In the BioHarmony Drug Report Database

"Preview" Icon

Pixantrone dimaleate

Pixuvri (pixantrone dimaleate) is a small molecule pharmaceutical. Pixantrone dimaleate was first approved as Pixuvri on 2012-05-10. It has been approved in Europe to treat non-hodgkin lymphoma.

 

Trade Name

 

Pixuvri
 

Common Name

 

pixantrone dimaleate
 

ChEMBL ID

 

CHEMBL2103844
 

Indication

 

non-hodgkin lymphoma
 

Drug Class

 

Antineoplastics, anthraquinone derivatives

Image (chem structure or protein)

Pixantrone dimaleate structure rendering